Skip to main content

Advertisement

Log in

Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to compare the health-related quality of life (HRQOL) of Chinese patients with prostate cancer against the general population and patients with colorectal cancer, breast cancer, nasopharyngeal cancer, and leukemia.

Methods

Chinese male patients (n = 291) with a confirmed diagnosis of prostate cancer were recruited from a urological specialist outpatient clinic in Hong Kong. HRQOL was measured by a condition-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P) and a generic Chinese (HK) SF-12 Health Survey Version 2 (SF-12v2) questionnaire. Mean HRQOL scores of condition-specific and generic questionnaires were compared to available scores derived from other cancers and age-matched male general population, respectively.

Results

Chinese patients with prostate cancer had lower general health and vitality domains and lower mental component summary scores than the age-matched Hong Kong normative population. Patients with prostate cancer reported better condition-specific HRQOL (physical well-being, emotional well-being and function well-being) when compared to general cancer population, patients with breast cancer, colorectal cancer, nasopharyngeal cancer, and leukemia in Hong Kong.

Conclusions

Patients with prostate cancer substantially perceived their HRQOL to be better, compared to patients with other cancers, with overall health, energy, and mental health below of Hong Kong general population. Interventions should target at these domains in order to improve the HRQOL of patients with prostate cancer. It is reassuring to find that prostate cancer had less negative impact on HRQOL than other cancer types did.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer Journal International du Cancer 127(12):2893–2917. doi:10.1002/ijc.25516

    Article  CAS  PubMed  Google Scholar 

  2. Eton DT, Lepore SJ (2002) Prostate cancer and health-related quality of life: a review of the literature. Psycho-Oncology 11(4):307–326. doi:10.1002/pon.572

    Article  PubMed Central  PubMed  Google Scholar 

  3. Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, Miralbell R, Zanetti R (2008) Recent trends in prostate cancer mortality show a continuous decrease in several countries. International Journal of Cancer Journal International du Cancer 123(2):421–429. doi:10.1002/ijc.23520

    Article  CAS  PubMed  Google Scholar 

  4. Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, Raisin CJ, Ornish D (2005) A qualitative analysis of interviews of men with early stage prostate cancer: the prostate cancer lifestyle trial. Cancer Nurs 28(2):99–107

    Article  PubMed  Google Scholar 

  5. Krupski TL, Fink A, Kwan L, Maliski S, Connor SE, Clerkin B, Litwin MS (2005) Health-related quality-of-life in low-income, uninsured men with prostate cancer. J Health Care Poor Underserved 16(2):375–390. doi:10.1353/hpu.2005.0037

    Article  PubMed  Google Scholar 

  6. Penson DF, Litwin MS, Aaronson NK (2003) Health related quality of life in men with prostate cancer. J Urol 169(5):1653–1661

    Article  PubMed  Google Scholar 

  7. Katz A (2007) Quality of life for men with prostate cancer. Cancer Nurs 30(4):302–308

    Article  PubMed  Google Scholar 

  8. Ishihara M, Suzuki H, Akakura K, Komiya A, Imamoto T, Tobe T, Ichikawa T (2006) Baseline health-related quality of life in the management of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association 13(7):920–925. doi:10.1111/j.1442-2042.2006.01441.x

    Article  Google Scholar 

  9. Rosenfeld B, Roth AJ, Gandhi S, Penson D (2004) Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psycho-Oncology 13(11):800–807

    Article  PubMed  Google Scholar 

  10. Zenger M, Lehmann-Laue A, Stolzenburg JU, Schwalenberg T, Ried A, Hinz A (2010) The relationship of quality of life and distress in prostate cancer patients compared to the general population. Psycho-social medicine 7:Doc02. doi:10.3205/psm000064

    PubMed Central  PubMed  Google Scholar 

  11. Ashing-Giwa KT (2005) The contextual model of HRQoL: a paradigm for expanding the HRQoL framework. Qual Life Res 14(2):297–307

    Article  PubMed  Google Scholar 

  12. Choi EP, Lam CL, Chin WY (2014) The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 23(10):2723–2733. doi:10.1007/s11136-014-0725-5

    Article  Google Scholar 

  13. Wong CKH, Choi EPH, Tsu JHL, Ho BSH, Ng ATL, Chin WY, Yiu MK (2015) Psychometric properties of functional assessment of cancer therapy-prostate (FACT-P) in Chinese patients with prostate cancer. Quality of Life Research 24(10):2397–2402. doi:10.1007/s11136-015-0993-8

  14. Ware JE, Kosinski M, Keller SD (1995) SF-12: how to score the SF-12 physical and mental health summary scales. Health Institute, New England Medical Center

    Google Scholar 

  15. Lam ET, Lam CL, Fong DY, Huang WW (2013) Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the Chinese? J Eval Clin Pract 19(1):200–208. doi:10.1111/j.1365-2753.2011.01800.x

    Article  PubMed  Google Scholar 

  16. Lam CL, Wong CH, Lam ET, Lo YY, Huang WW (2010) Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner 32(2):77–86

    Google Scholar 

  17. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ (1997) Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50(6):920–928. doi:10.1016/S0090-4295(97)00459-7

    Article  CAS  PubMed  Google Scholar 

  18. Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Medical care:S217-S232

  19. Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, SK O, Lee AW, Sham JS (2000) Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 88(7):1715–1727

    Article  CAS  PubMed  Google Scholar 

  20. Yu CL, Fielding R, Chan CL (2003) The mediating role of optimism on post-radiation quality of life in nasopharyngeal carcinoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 12(1):41–51

    Article  Google Scholar 

  21. Wong WS, Fielding R (2007) Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 15(11):1223–1230. doi:10.1007/s00520-006-0190-y

    Article  Google Scholar 

  22. Wong CK, Lam CL, Law WL, Poon JT, Kwong DL, Tsang J, Wan YF (2013) Condition-specific measure was more responsive than generic measure in colorectal cancer: all but social domains. J Clin Epidemiol 66(5):557–565. doi:10.1016/j.jclinepi.2012.11.010

    Article  PubMed  Google Scholar 

  23. Lau AK, Chang CH, Tai JW, Eremenco S, Liang R, Lie AK, Fong DY, Lau CM (2002) Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into traditional Chinese. Bone Marrow Transplant 29(1):41–49. doi:10.1038/sj.bmt.1703313

    Article  CAS  PubMed  Google Scholar 

  24. Wong CK, Lam CL, Poon JT, Kwong DL (2013) Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms. PLoS One 8(3):e58341. doi:10.1371/journal.pone.0058341

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Sloan JA, Cella D, Hays RD (2005) Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 58(12):1217–1219. doi:10.1016/j.jclinepi.2005.07.009

    Article  PubMed  Google Scholar 

  26. Thomas JC, Hersen M (2011) Understanding research in clinical and counseling psychology. Taylor & Francis

  27. Bloch S, Love A, Macvean M, Duchesne G, Couper J, Kissane D (2007) Psychological adjustment of men with prostate cancer: a review of the literature. BioPsychoSocial Medicine 1:2. doi:10.1186/1751-0759-1-2

    Article  PubMed Central  PubMed  Google Scholar 

  28. Kunkel EJ, Bakker JR, Myers RE, Oyesanmi O, Gomella LG (2000) Biopsychosocial aspects of prostate cancer. Psychosomatics 41(2):85–94. doi:10.1176/appi.psy.41.2.85

    Article  CAS  PubMed  Google Scholar 

  29. Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, Lewith G (2014) Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 4(3):e003901. doi:10.1136/bmjopen-2013-003901

    Article  PubMed Central  PubMed  Google Scholar 

  30. Dale W, Bilir P, Han M, Meltzer D (2005) The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer 104(3):467–478. doi:10.1002/cncr.21198

    Article  PubMed Central  PubMed  Google Scholar 

  31. Korfage IJ, Essink-Bot ML, Janssens AC, Schroder FH, de Koning HJ (2006) Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 94(8):1093–1098. doi:10.1038/sj.bjc.6603057

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Basaria S, Lieb 2nd J, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS (2002) Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56(6):779–786

    Article  CAS  Google Scholar 

  33. Alibhai SM, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60(3):201–215. doi:10.1016/j.critrevonc.2006.06.006

    Article  PubMed  Google Scholar 

  34. Leung PC (2010) Healthy aging. World Scientific Publishing Company, Singapore

    Google Scholar 

  35. Lahans T (2007) Integrating conventional and Chinese medicine in cancer care: a clinical guide. Churchill Livingstone, Edinburgh

    Google Scholar 

  36. Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak Piech C, Mody SH (2007) Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 23(4):731–739. doi:10.1185/030079907X178757

    Article  PubMed  Google Scholar 

  37. Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48(11):1507–1515

    Article  CAS  PubMed  Google Scholar 

  38. Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B (2008) Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 44(11):1497–1506. doi:10.1016/j.ejca.2008.03.017

    Article  PubMed  Google Scholar 

  39. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 8(1):33–39

    CAS  Google Scholar 

  40. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. Jama 273(2):129–135

    Article  CAS  PubMed  Google Scholar 

  41. Brandeis JM, Litwin MS, Burnison CM, Reiter RE (2000) Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163(3):851–857

    Article  CAS  PubMed  Google Scholar 

  42. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20(2):557–566

    Article  PubMed  Google Scholar 

  43. Choi E, Lam C, Chin W-Y (2014) Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes 12(1):1

    Article  PubMed Central  PubMed  Google Scholar 

  44. Cella D, Nichol MB, Eton D, Nelson JB, Mulani P (2009) Estimating clinically meaningful changes for the functional assessment of cancer therapy—prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health 12(1):124–129

    Article  PubMed  Google Scholar 

  45. Eton DT, Lepore SJ (2002) Prostate cancer and health-related quality of life: a review of the literature†. Psycho-Oncology 11(4):307

    Article  PubMed Central  PubMed  Google Scholar 

  46. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D’Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(9):1653–1659. doi:10.1200/JCO.2003.09.534

    Article  Google Scholar 

  47. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(16):3830–3842. doi:10.1200/JCO.2005.02.148

    Article  Google Scholar 

  48. Knight SJ, Chmiel JS, Kuzel T, Sharp L, Albers M, Fine R, Moran EM, Nadler RB, Sharifi R, Bennett CL (1998) Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol 160(5):1765–1769

    Article  CAS  PubMed  Google Scholar 

  49. Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, Kuzel TM, Nadler RB, Bennett CL (2001) Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Investig 19(7):684–691

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to express their gratitude to Professor Cindy L.K. Lam for the design and planning of this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edmond P. H. Choi.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choi, E.P.H., Wong, C.K.H., Tsu, J.H.L. et al. Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations. Support Care Cancer 24, 1849–1856 (2016). https://doi.org/10.1007/s00520-015-2980-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2980-6

Keywords

Navigation